Page 1940 - Hematology_ Basic Principles and Practice ( PDFDrive )

1720 Part XI Transfusion Medicine

12. Slichter SJ, Kaufman RM, Assmann SF, et al: Dose of prophylactic 21. Seltsam A, Müller TH: Update on the use of pathogen-reduced human
platelet transfusions and prevention of hemorrhage. N Engl J Med plasma and platelet concentrates. Br J Haematol 162(4):442–454,
362(7):600–613, 2010. 2013.
13. Wandt H, Schaefer-Eckart K, Wendelin K, et al: Therapeutic platelet 22. McCullough J: Therapeutic efficacy and safety of platelets treated with
transfusion versus routine prophylactic transfusion in patients with a photochemical process for pathogen inactivation: the SPRINT Trial.
haematological malignancies: an open-label, multicentre, randomised Blood 104(5):1534–1541, 2004.
study. The Lancet. 380(9850):1309–1316, 2012. 23. Kaufman RM, Assmann SF, Triulzi DJ, et al: Transfusion-related adverse
14. Stanworth SJ, Estcourt LJ, Powter G, et al: A no-prophylaxis events in the Platelet Dose study. Transfusion 2014. doi: 10.1111/
platelet-transfusion strategy for hematologic cancers. N Engl J Med trf.12791. n/a–n/a.
368(19):1771–1780, 2013. 24. Heddle NM, Klama L, Meyer R, et al: A randomized controlled trial
15. Kaufman RM, Djulbegovic B, Gernsheimer T, et al: Platelet Transfu- comparing plasma removal with white cell reduction to prevent reactions
sion: A Clinical Practice Guideline From the AABB. Ann Intern Med to platelets. Transfusion 39(3):231–238, 1999.
162(3):205–213, 2015. 25. Tobian AAR, Fuller AK, Uglik K, et al: The impact of platelet additive
16. Howard SC, Gajjar A, Ribeiro RC, et al: Safety of lumbar puncture solution apheresis platelets on allergic transfusion reactions and corrected
for children with acute lymphoblastic leukemia and thrombocytopenia. count increment (CME). Transfusion 54(6):1523–1529, 2013.
JAMA 284(17):2222–2224, 2000. 26. Josephson CD, Castillejo M-I, Grima K, et al: ABO-mismatched platelet
17. Vavricka SR, Walter RB, Irani S, et al: Safety of lumbar puncture for transfusions: Strategies to mitigate patient exposure to naturally occur-
adults with acute leukemia and restrictive prophylactic platelet transfu- ring hemolytic antibodies. Transfus Apher Sci 42(1):83–88, 2010.
sion. Ann Hematol 82(9):570–573, 2003. 27. Toy P, Gajic O, Bacchetti P, et al: Transfusion related acute lung injury:
18. Bishop JF, Schiffer CA, Aisner J, et al: Surgery in acute leukemia: a incidence and risk factors. Blood 119(7):1757–1767, 2012.
review of 167 operations in thrombocytopenic patients. Am J Hematol 28. Cid J, Lozano M, Fernández-Avilés F, et al: Anti-D alloimmunization
26(2):147–155, 1987. after D-mismatched allogeneic hematopoietic stem cell transplantation
19. Murphy S, Gardner FH: Effect of storage temperature on maintenance in patients with hematologic diseases. Transfusion 46(2):169–173,
of platelet viability–deleterious effect of refrigerated storage. N Engl J 2006.
Med 280(20):1094–1098, 1969. 29. Dzik S: How I do it: platelet support for refractory patients. Transfusion
20. Eder AF, Kennedy JM, Dy BA, et al: Bacterial screening of apheresis 47(3):374–378, 2007.
platelets and the residual risk of septic transfusion reactions: the Ameri- 30. Vassallo RR, Fung M, Rebulla P, et al: Utility of cross-matched platelet
can Red Cross experience (2004–2006). Transfusion 47(7):1134–1142, transfusions in patients with hypoproliferative thrombocytopenia: a
2007. systematic review. Transfusion 54(4):1180–1191, 2013.